| Fibroblast growth factor 23-mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study. | Fibroblast growth factor 23-mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study.
Zhang X, Xu J., Free PMC Article | 08/29/2024 |
| Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders. | Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders.
Takashi Y, Kawanami D, Fukumoto S. | 07/12/2024 |
| Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease. | Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease.
Nakagawa Y, Komaba H., Free PMC Article | 07/10/2024 |
| A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells. | A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells.
Zhang X, Xu J. | 06/27/2024 |
| FGF23 facilitates IL-1beta synthesis in rheumatoid arthritis through activating PI3K, Akt, and NF-kappaB pathways. | FGF23 facilitates IL-1β synthesis in rheumatoid arthritis through activating PI3K, Akt, and NF-κB pathways.
Hu SL, Thadevoos LA, Ho TL, Lin YY, Chen HT, Huang CC, Su CM, Tang CH. | 06/13/2024 |
| FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease. | FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.
Donate-Correa J, Martín-Núñez E, Hernández-Carballo C, González-Luis A, Mora-Fernández C, Martín-Olivera A, Rodríguez-Ramos S, Cerro-López P, López-Castillo Á, Delgado-Molinos A, López-Tarruella VC, Navarro-González JF., Free PMC Article | 06/10/2024 |
| Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes. | Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes.
Vermeulen S, Scheffer-Rath MEA, Besouw MTP, van der Vaart A, de Borst MH, Boot AM., Free PMC Article | 05/30/2024 |
| Relationships of serum FGF23 and alpha-klotho with atherosclerosis in patients with type 2 diabetes mellitus. | Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus.
Bi J, Zheng M, Li K, Sun S, Zhang Z, Yan N, Li X., Free PMC Article | 04/22/2024 |
| ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress. | ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress.
Jung YS, Radhakrishnan K, Hammad S, Müller S, Müller J, Noh JR, Kim J, Lee IK, Cho SJ, Kim DK, Kim YH, Lee CH, Dooley S, Choi HS., Free PMC Article | 04/3/2024 |
| Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies. | Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies.
Wungu CDK, Susilo H, Alsagaff MY, Witarto BS, Witarto AP, Pakpahan C, Gusnanto A., Free PMC Article | 03/13/2024 |
| Serum alpha-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus. | Serum α-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus.
Oner C, Dogan B, Tuzun S, Ekinci A, Feyizoglu G, Basok BI., Free PMC Article | 03/4/2024 |
| Inherited fibroblast growth factor 23 excess. | Inherited fibroblast growth factor 23 excess.
Cherian KE, Paul TV. | 02/28/2024 |
| Decreased FGF23 inhibits placental angiogenesis via the ERK1/2-EGR-1 signaling pathway in preeclampsia. | Decreased FGF23 inhibits placental angiogenesis via the ERK1/2-EGR-1 signaling pathway in preeclampsia.
Zhao S, Zhou J, Chen R, Zhou W, Geng H, Huang Y, Shi S, Yuan L, Wang Z, Wang D. | 02/27/2024 |
| The Relationship Between Serum Fibroblast Growth Factor 23 and Klotho Protein and Low Bone Mineral Density in Middle-Aged and Elderly Patients with End-Stage Renal Disease. | The Relationship Between Serum Fibroblast Growth Factor 23 and Klotho Protein and Low Bone Mineral Density in Middle-Aged and Elderly Patients with End-Stage Renal Disease.
Huang T, He Y, Li Y, Zhang H, Wang Q, Gao Y. | 02/7/2024 |
| Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation. | Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation.
Radvanyi Z, Yoo EJ, Kandasamy P, Salas-Bastos A, Monnerat S, Refardt J, Christ-Crain M, Hayashi H, Kondo Y, Jantsch J, Rubio-Aliaga I, Sommer L, Wagner CA, Hediger MA, Kwon HM, Loffing J, Pathare G., Free PMC Article | 02/7/2024 |
| Associations between anemia and FGF23 in the CKiD study. | Associations between anemia and FGF23 in the CKiD study.
Thomas E, Klomhaus AM, Laster ML, Furth SL, Warady BA, Salusky IB, Hanudel MR., Free PMC Article | 02/6/2024 |
| Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome. | Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
Kallmeyer A, Pello A, Cánovas E, Aceña Á, González-Casaus ML, Tarín N, Cristóbal C, Gutiérrez-Landaluce C, Huelmos A, Rodríguez-Valer A, González-Lorenzo Ó, Alonso J, López-Bescós L, Egido J, Mahillo I, Lorenzo Ó, Tuñón J., Free PMC Article | 02/2/2024 |
| Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in Chronic Kidney Disease: A systematic review with meta-analysis. | Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in Chronic Kidney Disease: A systematic review with meta-analysis.
Castillo RF, Pérez RG, González AL., Free PMC Article | 01/9/2024 |
| Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease. | Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease.
Watanabe K, Fujii H, Okamoto K, Kono K, Goto S, Nishi S., Free PMC Article | 01/8/2024 |
| [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity]. | [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].
Ovchinnikov AY, Khon EM, Bakotina AV, Miroshnichenko NA, Gronskaia SA, Belaya ZE. | 01/8/2024 |
| Changes of FGF23 and hearing in chronic renal failure and their correlation analysis. | Changes of FGF23 and hearing in chronic renal failure and their correlation analysis.
Li J, Nie J, Zhou Z, Guo M, Yang Q, Yuan D, Huang J, Li R, Li Q. | 01/5/2024 |
| FGF23 and klotho at the intersection of kidney and cardiovascular disease. | FGF23 and klotho at the intersection of kidney and cardiovascular disease.
Edmonston D, Grabner A, Wolf M. | 12/20/2023 |
| GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/beta-catenin signaling pathway. | GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway.
Guo L, Wang Y, Li S, Zhou L, Li D. | 11/13/2023 |
| Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus. | Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus.
Hocher CF, Chen X, Zuo J, Horvathova K, Hocher B, Krämer BK, Chu C. | 11/7/2023 |
| High Circulating FGF-23 and Its Relationship with Severity of Spinal Involvement in Diffuse Idiopathic Skeletal Hyperostosis. | High Circulating FGF-23 and Its Relationship with Severity of Spinal Involvement in Diffuse Idiopathic Skeletal Hyperostosis.
Zhou H, Xu H, Gong J, Li Z, Sun X. | 11/6/2023 |